Holen Sie sich die Stockscreener-App
1.42
0.71%
0.01
Vorhandelsmarkt:
1.40
-0.02
-1.41%
Schlusskurs vom Vortag:
$1.41
Offen:
$1.41
24-Stunden-Volumen:
121.94K
Relative Volume:
0.20
Marktkapitalisierung:
$5.83M
Einnahmen:
$502.40K
Nettoeinkommen (Verlust:
$-7.91M
KGV:
-0.1424
EPS:
-9.972
Netto-Cashflow:
$-4.32M
1W Leistung:
+11.81%
1M Leistung:
+6.77%
6M Leistung:
-21.55%
1J Leistung:
-78.81%
1-Tages-Spanne:
$1.36
$1.46
1-Wochen-Bereich:
$1.215
$1.46
52-Wochen-Spanne:
$1.215
$12.45
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Firmenname
60 Degrees Pharmaceuticals Inc
Sektor
Branche
Telefon
202-327-5422
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
Vergleichen Sie SXTP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.42 | 5.79M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
401.00 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.90 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.00 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
706.41 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.04 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten
60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference - uk.finance.yahoo.com
Can volume confirm reversal in 60 Degrees Pharmaceuticals Inc. Equity WarrantWeekly Gains Summary & Technical Analysis for Trade Confirmation - Newser
Custom watchlist performance reports with 60 Degrees Pharmaceuticals Inc. Equity Warrant - Newser
How to build a custom watchlist for 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Big Picture & Risk Managed Investment Entry Signals - Newser
Using data tools to time your 60 Degrees Pharmaceuticals Inc. exitTrade Analysis Report & Real-Time Volume Surge Alerts - Newser
Regression analysis insights on 60 Degrees Pharmaceuticals Inc. performanceLayoff News & Daily Volume Surge Trade Alerts - Newser
Is 60 Degrees Pharmaceuticals Inc. meeting your algorithmic filter criteriaTrade Risk Summary & Weekly Top Gainers Trade List - Newser
Forecasting 60 Degrees Pharmaceuticals Inc. price range with options dataJuly 2025 Weekly Recap & Community Consensus Stock Picks - Newser
Does 60 Degrees Pharmaceuticals Inc. Equity Warrant fit your quant trading modelEarnings Risk Report & High Yield Stock Recommendations - Newser
How to escape a deep drawdown in 60 Degrees Pharmaceuticals Inc.Weekly Risk Report & Advanced Swing Trade Entry Plans - Newser
Can 60 Degrees Pharmaceuticals Inc. maintain sales growthJuly 2025 Spike Watch & Smart Allocation Stock Reports - خودرو بانک
What’s the outlook for 60 Degrees Pharmaceuticals Inc. Equity Warrant’s sectorTrade Analysis Report & Low Volatility Stock Recommendations - خودرو بانک
Applying chart zones and confluence areas to 60 Degrees Pharmaceuticals Inc.2025 Support & Resistance & Daily Risk Controlled Trade Plans - Newser
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock ready for a breakoutQuarterly Profit Summary & Weekly Top Performers Watchlists - Newser
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant benefit from government policy2025 Analyst Calls & Technical Pattern Based Signals - خودرو بانک
Is 60 Degrees Pharmaceuticals Inc. a cyclical or defensive stock2025 Technical Overview & Expert Approved Momentum Ideas - خودرو بانک
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant benefit from rising consumer demandJuly 2025 Breakouts & Verified Momentum Watchlists - خودرو بانک
Using data tools to time your 60 Degrees Pharmaceuticals Inc. Equity Warrant exit2025 Big Picture & Accurate Entry and Exit Point Alerts - Newser
What institutional flow reveals about 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Setups & Detailed Earnings Play Strategies - Newser
Does 60 Degrees Pharmaceuticals Inc. Equity Warrant offer margin of safetyQuarterly Risk Review & Technical Analysis for Trade Confirmation - خودرو بانک
Building trade automation scripts for 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Price Action Summary & Verified Momentum Stock Ideas - Newser
Combining price and volume data for 60 Degrees Pharmaceuticals Inc.July 2025 Reactions & Free Reliable Trade Execution Plans - Newser
Intraday pattern recognizer results for 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Technical Patterns & Long-Term Growth Portfolio Plans - Newser
Multi asset correlation models including 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Biggest Moves & Fast Moving Market Watchlists - Newser
Is 60 Degrees Pharmaceuticals Inc. forming a double bottomTrade Risk Summary & Technical Pattern Recognition Alerts - خودرو بانک
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock undervalued right now2025 Trading Volume Trends & Weekly Stock Performance Updates - خودرو بانک
Will 60 Degrees Pharmaceuticals Inc. benefit from rate cutsMarket Weekly Review & Weekly Chart Analysis and Guides - خودرو بانک
Visual analytics tools that track 60 Degrees Pharmaceuticals Inc. Equity Warrant performance2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
Sentiment analysis tools applied to 60 Degrees Pharmaceuticals Inc. Equity WarrantShare Buyback & Growth Focused Stock Reports - Newser
What are 60 Degrees Pharmaceuticals Inc.’s earnings expectations2025 Growth vs Value & AI Powered Market Entry Ideas - خودرو بانک
Can 60 Degrees Pharmaceuticals Inc. be recession proofExit Point & Technical Pattern Alert System - خودرو بانک
Can a trend reversal in 60 Degrees Pharmaceuticals Inc. lead to recovery2025 AllTime Highs & Daily Profit Focused Screening - Newser
Market reaction to 60 Degrees Pharmaceuticals Inc. Equity Warrant’s recent newsQuarterly Earnings Summary & Detailed Earnings Play Strategies - Newser
Heatmap analysis for 60 Degrees Pharmaceuticals Inc. Equity Warrant and competitorsJuly 2025 Update & AI Driven Price Predictions - Newser
Intraday pattern recognizer results for 60 Degrees Pharmaceuticals Inc.Weekly Trade Recap & Weekly Hot Stock Watchlists - Newser
What technical models suggest about 60 Degrees Pharmaceuticals Inc.’s comebackWeekly Gains Report & Reliable Volume Spike Trade Alerts - Newser
Has 60 Degrees Pharmaceuticals Inc. Equity Warrant found a price floorStock Surge & Weekly High Return Stock Opportunities - Newser
Does 60 Degrees Pharmaceuticals Inc. qualify in momentum factor screeningMarket Sentiment Report & AI Forecast for Swing Trade Picks - Newser
60 Degrees Pharmaceuticals Inc. Equity Warrant’s volatility index tracking explainedEarnings Miss & Breakout Confirmation Alerts - Newser
Tools to assess 60 Degrees Pharmaceuticals Inc.’s risk profileInflation Watch & Reliable Intraday Trade Plans - Newser
Does 60 Degrees Pharmaceuticals Inc. fit your quant trading modelWeekly Stock Analysis & Weekly Setup with High ROI Potential - Newser
What the charts say about 60 Degrees Pharmaceuticals Inc. Equity Warrant todayJuly 2025 Update & Consistent Return Strategy Ideas - Newser
60 Degrees Pharmaceuticals Inc. stock trendline breakdownRate Cut & Free Weekly Watchlist of Top Performers - Newser
Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)
Umsatz
Nettogewinn
Free Cashflow
ENV
60 Degrees Pharmaceuticals Inc-Aktie (SXTP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 13 '24 |
Buy |
1.56 |
6,000 |
9,375 |
52,078 |
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
4.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):